SARS-CoV-2: Infection Models and Vaccines
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Virology".
Deadline for manuscript submissions: closed (31 July 2023) | Viewed by 4990
Special Issue Editor
Special Issue Information
Dear Colleagues,
The emergence of SARS-CoV-2 presents a considerable challenge for the scientific community and public health. However, the development of vaccines, monoclonal antibodies and antivirals has been spectacular. This accumulation of knowledge has led to a better understanding of COVID-19 and the progression of the disease in patients. Nevertheless, some factors for poor prognosis are not well-understood, for example those faced by the diabetic population. Moreover, mechanisms of escape selection, notably through the emergence of variants, are not well-characterized either. We are pleased to invite you to submit research articles regarding vaccine studies or infection models of SARS-CoV-2. Both in vitro and in vivo models are a complementary approach to describe and explore SARS-CoV-2, and these fundamental experiments could help to elucidate some of these questions.
In this Special Issue, original research articles and reviews are welcome, as the current pandemic requires continuous innovation.
I look forward to receiving your contributions.
Dr. Julien Andréani
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- SARS-CoV-2
- COVID-19
- in vitro models
- in vivo models
- vaccines
- antivirals
- monoclonal antibodies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
